| Financial Year |
March 31 2023 |
| Monetary Funds |
594,435,397.72 |
| Held-for-trading Financial Assets |
80,768.13 |
| Notes Receivable |
13,517,889.87 |
| Accounts Receivable |
305,418,590.22 |
| Advances to Suppliers |
21,629,220.98 |
| Other Receivables |
21,229,421.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
248,870,591.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
742,828.26 |
| Total Current Assets |
1,292,051,328.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
41,454,601.46 |
| Investment Properties |
-- |
| Fixed Assetes |
123,807,572.62 |
| Under-construction Projects |
1,121,680.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
13,613,026.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
20,370,696.24 |
| Other Non-Current Assets |
38,783,610.86 |
| Sub-Total of Non-Current Assets |
239,151,188.50 |
| Total Assets |
1,531,202,516.52 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
51,694,339.03 |
| Accounts Payable |
195,105,582.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,306,994.43 |
| Taxes Payable |
4,235,819.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,738,963.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
32,363,309.14 |
| Sub-Total of Current Liabilities |
522,664,717.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,508,123.97 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,461,217.56 |
| Total Liabilities |
535,125,934.66 |
| Paid-In Capital(Or Share Stock) |
71,276,123.00 |
| Capital Surplus |
616,247,119.46 |
| Surplus Reserve |
31,988,743.42 |
| LESS:Treasury Stock |
19,899,000.00 |
| Undistributed Profits |
231,615,516.38 |
| Minority Stockholder's Interest |
64,848,079.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
931,228,502.26 |
| Owner's Equity（Stockholder's Equity） |
996,076,581.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,531,202,516.52 |
